When did Moderna report Q3 2025 earnings?

Moderna (MRNA) reported Q3 2025 earnings on November 6, 2025 before market open.

What were Moderna's Q3 2025 revenue and EPS?

Moderna reported revenue of $1.0B and diluted EPS of $-0.51 for Q3 2025.

Did Moderna beat estimates in Q3 2025?

Revenue beat the consensus estimate of $920.9M by $95.1M. EPS beat the consensus estimate of $-1.87 by $1.36.

How did Moderna's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue declined 45.2% from $1.9B a year earlier.

Where can I find Moderna's Q3 2025 SEC filings?

You can read the 8-K earnings release (0001682852-25-000073) and the 10-Q periodic report (0001682852-25-000075) directly on SEC EDGAR. The filing index links above go to sec.gov.

Moderna MRNA Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$1.0BBeat by $95.1M Diluted EPS-$0.51Beat by $1.36

Revenue estimate$920.9M

EPS estimate-$1.87

Next report

Jul 31, 2026 (In 3 weeks)

Revenue estimate$101.7M

EPS estimate-$2.00

Financials

Q3 2025

Income statement

See full

Revenue$1.0B-45.4%

Gross profit$809.0M-40.0%

Operating income-$260.0M-271%

Net income-$200.0M-1,638%

EPS (diluted)-$0.51-1,800%

Balance sheet

See full

Cash & equivalents$1.1B-31.1%

Total debt$765.0M-44.8%

Total equity$9.3B-21.8%

Total assets$12.1B-23.2%

Cash flow

See full

Operating cash flow-$847.0M+45.9%

CapEx$33.0M-78.1%

Free cash flow-$880.0M+48.7%

Valuation & ratios

Valuation

as of 09/30/25

See full

Market cap$10.05B-60.9%

Enterprise value$9.68B-61.9%

P/S4.5×-0.6×

Profitability

See full

Gross margin48.3%-19.2pp

Operating margin-155.2%-324pp

Net margin-139.6%-294pp

FCF margin-132.4%—

Returns & leverage

See full

Return on equity-29.3%+32.3pp

Debt / equity0.1×0.0×

Current ratio3.9×-0.5×

Segments

By product

See full

Grant revenue$14.0M+100%

Collaboration Arrangement, Including Arrangements With Affiliate$7.0M-75.0%

Licensing and royalty revenue$2.0M-71.4%

By geography

See full

Europe$13.3M-91.1%

Versus estimates

Revenue

Q1 2026$389.0MBeat by $152.6M Q4 2025$678.0MBeat by $42.8M

Q3 2025$1.0BBeat by $95.1M

Q2 2025$142.0MMiss by $751.3M Q1 2025$107.0MMiss by $9.7M Q4 2024$956.0MBeat by $13.2M

Diluted EPS

Q1 2026-$1.18Beat by $1.84 Q4 2025-$2.11Beat by $0.43

Q3 2025-$0.51Beat by $1.36

Q2 2025-$2.13Beat by $0.86 Q1 2025-$2.52Beat by $0.40 Q4 2024-$2.50Beat by $0.18

Ask the moment Moderna reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Moderna report Q3 2025 earnings?: Moderna (MRNA) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Moderna's Q3 2025 revenue and EPS?: Moderna reported revenue of $1.0B and diluted EPS of $-0.51 for Q3 2025.
Did Moderna beat estimates in Q3 2025?: Revenue beat the consensus estimate of $920.9M by $95.1M. EPS beat the consensus estimate of $-1.87 by $1.36.
How did Moderna's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 45.2% from $1.9B a year earlier.
Where can I find Moderna's Q3 2025 SEC filings?: You can read the 8-K earnings release (0001682852-25-000073) and the 10-Q periodic report (0001682852-25-000075) directly on SEC EDGAR. The filing index links above go to sec.gov.